Despite advances in defibrillation technology, shock-refractory ventricular fibrillation remains common during out-of-hospital cardiac arrest. Double sequential external defibrillation (DSED ...

In order to remove obstacles preventing immediate defibrillation, the medical community and the media worked together to highlight the importance of public access defibrillation. Under increasing ...

CPR Therapeutics Inc. announced today that the company has received a continuation U.S. patent for technology that underlies ...

Researchers used data from the Portland Cardiac Arrest Epidemiologic Registry, which comprehensively recorded the placement position of defibrillation pads from July 1, 2019, through June 30, 2023.

The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ventricle. This new 4.7 French (1.6mm ...

Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle Heart Rhythm 2025 ...

Blood pressure checks carried out at a Staffordshire school during a training session found a teacher was having a silent ...

Both cardioversion and defibrillation can use a manual device to administer electrical impulses to the heart. According to a 2021 article, the main difference between them is the timing and method ...